Alitretinoin und Off-label-Use

[1]  T. Ruzicka,et al.  Successful therapy of refractory Hailey–Hailey disease with oral alitretinoin , 2014, The British journal of dermatology.

[2]  E. Bierhoff,et al.  Alitretinoin: an effective treatment option for pagetoid reticulosis , 2013, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[3]  C. Munro,et al.  Successful treatment with oral alitretinoin in women of childbearing potential with Darier's disease , 2013, The British journal of dermatology.

[4]  T. Ruzicka,et al.  Treatment of Darier disease with oral alitretinoin , 2013, Clinical and experimental dermatology.

[5]  B. Bonnekoh,et al.  Complete remission of alopecia areata under treatment of chronic hand eczema with alitretinoin. , 2013, European journal of dermatology : EJD.

[6]  A. Kerstan,et al.  Combined oral alitretinoin and narrowband UVB treatment of cutaneous T cell lymphoma: favourable response after multiple ineffective systemic therapies. , 2012, European journal of dermatology : EJD.

[7]  A. Tejera-Vaquerizo,et al.  Tratamiento exitoso de un ezcema crónico recalcitrante de las plantas con alitretinoína , 2012 .

[8]  A. Tejera-Vaquerizo,et al.  Successful treatment of recalcitrant chronic foot eczema with alitertinoin. , 2012, Actas dermo-sifiliograficas.

[9]  A. Navarini,et al.  Alitretinoin abrogates innate inflammation in palmoplantar pustular psoriasis , 2012, The British journal of dermatology.

[10]  T. Luger,et al.  Alitretinoin for cutaneous lupus erythematosus. , 2012, Journal of the American Academy of Dermatology.

[11]  A. Gånemo,et al.  Oral alitretinoin in congenital ichthyosis: a pilot study shows variable effects and a risk of central hypothyroidism. , 2012, Acta dermato-venereologica.

[12]  S. E. Barnstedt.  Erfolgreiche Therapie eines Morbus Darier mit Alitretinoin , 2012, Der Hautarzt.

[13]  R. Kaufmann,et al.  Lichen planus of nails – successful treatment with Alitretinoin , 2011, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[14]  F. Toberer,et al.  Keratitis-ichthyosis-deafness syndrome: response to alitretinoin and review of literature. , 2011, Archives of dermatology.

[15]  H. Haenssle,et al.  Response of recalcitrant lichen planus to alitretinoin in 3 patients. , 2011, Journal of the American Academy of Dermatology.

[16]  L. Schmitt,et al.  Oral Alitretinoin for the Treatment of Recalcitrant Pityriasis Rubra Pilaris , 2011, Case Reports in Dermatology.

[17]  T. Luger,et al.  Successful treatment of palmoplantar hyperkeratotic psoriasis with a combination of etanercept and alitretinoin. , 2011, The Journal of clinical and aesthetic dermatology.

[18]  T. Ruzicka,et al.  Oral alitretinoin in lichen planus: two case reports. , 2010, Acta dermato-venereologica.

[19]  D. Rigopoulos,et al.  Efficacy and safety of tacrolimus ointment 0·1% vs. betamethasone 17‐valerate 0·1% in the treatment of chronic paronychia: an unblinded randomized study. Reply from authors , 2010 .

[20]  T. Ruzicka,et al.  Treatment of refractory pityriasis rubra pilaris with oral alitretinoin: case report , 2010, The British journal of dermatology.

[21]  T. Agner,et al.  Changes in skin barrier during treatment with systemic alitretinoin: focus on skin susceptibility and stratum corneum ceramides , 2010, Archives of Dermatological Research.

[22]  A. Wollenberg,et al.  Treatment of atopic eczema with oral alitretinoin , 2010, The British journal of dermatology.

[23]  T. Ruzicka,et al.  Possible benefit of oral alitretinoin in T‐lymphoproliferative diseases: a report of two patients with palmoplantar hyperkeratotic‐rhagadiform skin changes and mycosis fungoides or Sézary syndrome , 2009, The British journal of dermatology.

[24]  B. Piraccini,et al.  Evaluation of the efficacy of acitretin therapy for nail psoriasis. , 2009, Archives of dermatology.

[25]  G. Jemec,et al.  Alitretinoin – its use in intractable hand eczema and other potential indications , 2009, Drug design, development and therapy.

[26]  K. Herbert,et al.  Retinoic acid and retinoid receptors: potential chemopreventive and therapeutic role in cervical cancer. , 2005, The Lancet. Oncology.

[27]  L. Baumann,et al.  Open-label pilot study of alitretinoin gel 0.1% in the treatment of photoaging. , 2005, Cutis.

[28]  Diane D. Liu,et al.  9-cis-Retinoic Acid Treatment Increases Serum Concentrations of α-Tocopherol in Former Smokers , 2005, Clinical Cancer Research.

[29]  S. Shumack,et al.  Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials , 2005, The British journal of dermatology.

[30]  M. Sotto,et al.  Acitretin and skin cancer in kidney transplanted patients. Clinical and histological evaluation and immunohistochemical analysis of lymphocytes, natural killer cells and Langerhans’ cells in sun exposed and sun protected skin , 2005, Clinical transplantation.

[31]  Diane D. Liu,et al.  Treatment of former smokers with 9-cis-retinoic acid reverses loss of retinoic acid receptor-beta expression in the bronchial epithelium: results from a randomized placebo-controlled trial. , 2003, Journal of the National Cancer Institute.

[32]  C. Zouboulis.  Retinoids – Which Dermatological Indications Will Benefit in the Near Future? , 2001, Skin Pharmacology and Physiology.

[33]  M. Merino,et al.  Phase I clinical trial of alitretinoin and tamoxifen in breast cancer patients: toxicity, pharmacokinetic, and biomarker evaluations. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  P. Mclaughlin,et al.  Experience with 9-Cis Retinoic Acid in Patients with Relapsed and Refractory Non-Hodgkin's Lymphoma , 2000, Leukemia & lymphoma.

[35]  J. Marshall,et al.  Phase I study of 9-cis-retinoic acid (ALRT1057 capsules) in adults with advanced cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[36]  Anolik,et al.  Effect of isotretinoin therapy on natural killer cell activity in patients with xeroderma pigmentosum , 1998, The British journal of dermatology.

[37]  L. Degos.  Differentiating agents in the treatment of leukemia. , 1990, Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis.

[38]  W. Fujimoto,et al.  Expression of retinoic acid receptor genes in keratinizing front of skin , 1989, FEBS letters.